Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy West Pharmaceutical Services stock
Learn how to easily invest in West Pharmaceutical Services stock.
West Pharmaceutical Services is a medical instruments & supplies business based in the US. West Pharmaceutical Services shares (WST) are listed on the NYSE and all prices are listed in US Dollars. West Pharmaceutical Services employs 10,700 staff and has a trailing 12-month revenue of around $2.9 billion.
How to buy West Pharmaceutical Services stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – WST. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Commission-free stock and ETF trades
- No management fees
- Customizable portfolios with automatic rebalancing
What's in this guide?
- WST shares summary
- Compare share dealing platforms
- Is WST stock a buy or sell?
- Stock performance over time
- Are WST shares over-valued?
- West Pharmaceutical Services's financials
- How volatile are WST shares?
- Does West Pharmaceutical Services pay a dividend?
- Have WST shares ever split?
- Other common questions
West Pharmaceutical Services stock price (NYSE: WST)Use our graph to track the performance of WST stocks over time.
West Pharmaceutical Services shares at a glance
|Latest market close||$343.73|
|52-week range||$205.76 - $376.72|
|50-day moving average||$353.15|
|200-day moving average||$287.67|
|Wall St. target price||$369.22|
|Dividend yield||$0.74 (0.22%)|
|Earnings per share (TTM)||$7.27|
Buy West Pharmaceutical Services stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy West Pharmaceutical Services stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
West Pharmaceutical Services price performance over time
Historical closes compared with the close of $343.73 from 2023-06-02
|1 week (2023-05-26)||0.07%|
|1 month (2023-05-05)||-6.71%|
|3 months (2023-03-03)||4.39%|
|6 months (2022-12-05)||43.56%|
|1 year (2022-06-01)||11.39%|
|2 years (2021-06-02)||2.98%|
|3 years (2020-06-05)||67.46%|
|5 years (2018-06-05)||266.09%|
Is West Pharmaceutical Services stock undervalued or overvalued?
Valuing West Pharmaceutical Services stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of West Pharmaceutical Services's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
West Pharmaceutical Services's P/E ratio
West Pharmaceutical Services's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 47x. In other words, West Pharmaceutical Services shares trade at around 47x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
West Pharmaceutical Services's PEG ratio
West Pharmaceutical Services's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.0596. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into West Pharmaceutical Services's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
West Pharmaceutical Services's EBITDA
West Pharmaceutical Services's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $864.8 million.
The EBITDA is a measure of a West Pharmaceutical Services's overall financial performance and is widely used to measure a its profitability.
West Pharmaceutical Services financials
|Revenue TTM||$2.9 billion|
|Operating margin TTM||25.74%|
|Gross profit TTM||$1.1 billion|
|Return on assets TTM||13.22%|
|Return on equity TTM||21.64%|
|Market capitalisation||$25.5 billion|
TTM: trailing 12 months
West Pharmaceutical Services share dividends
Dividend payout ratio: 9.09% of net profits
Recently West Pharmaceutical Services has paid out, on average, around 9.09% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.22% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), West Pharmaceutical Services shareholders could enjoy a 0.22% return on their shares, in the form of dividend payments. In West Pharmaceutical Services's case, that would currently equate to about $0.74 per share.
While West Pharmaceutical Services's payout ratio might seem low, this can signify that West Pharmaceutical Services is investing more in its future growth.
West Pharmaceutical Services's most recent dividend payout was on 2 August 2023. The latest dividend was paid out to all shareholders who bought their shares by 25 July 2023 (the "ex-dividend date").
Have West Pharmaceutical Services's shares ever split?
West Pharmaceutical Services's shares were split on a 2:1 basis on 27 September 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your West Pharmaceutical Services shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for West Pharmaceutical Services shares which in turn could have impacted West Pharmaceutical Services's share price.
West Pharmaceutical Services share price volatility
Over the last 12 months, West Pharmaceutical Services's shares have ranged in value from as little as $205.7632 up to $376.72. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while West Pharmaceutical Services's is 1.0911. This would suggest that West Pharmaceutical Services's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
West Pharmaceutical Services overview
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
West Pharmaceutical Services in the news
Cooper Companies (COO) Q2 Earnings and Revenues Beat Estimates
Stryker's (SYK) Q Guidance Successful in First Surgery
Abbott (ABT) Reports Upbeat Cardiomems Sensor Study Result
Frequently asked questionsWhat percentage of West Pharmaceutical Services is owned by insiders or institutions?
Currently 0.526% of West Pharmaceutical Services shares are held by insiders and 95.055% by institutions. How many people work for West Pharmaceutical Services?
Latest data suggests 10,700 work at West Pharmaceutical Services. When does the fiscal year end for West Pharmaceutical Services?
West Pharmaceutical Services's fiscal year ends in December. Where is West Pharmaceutical Services based?
West Pharmaceutical Services's address is: 530 Herman O. West Drive, Exton, PA, United States, 19341-0645 What is West Pharmaceutical Services's ISIN number?
West Pharmaceutical Services's international securities identification number is: US9553061055 What is West Pharmaceutical Services's CUSIP number?
West Pharmaceutical Services's Committee on Uniform Securities Identification Procedures number is: 953348109
More guides on Finder
JP Morgan Personal Advisors review 2023
Access remote advice, planning and portfolio management from this established financial services company.
How to buy Energy Transfer Equity stock
Steps to owning and managing ET, with 24-hour and historical pricing before you buy.
How to buy Uranium Energy stock
Steps to owning and managing UEC, with 24-hour and historical pricing before you buy.
How to buy Gold Royalty stock
Steps to owning and managing GROY, with 24-hour and historical pricing before you buy.
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
Best online brokers & platforms to buy gold stocks in June 2023
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
How to buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
Ask an Expert